Cargando…

Stage II colorectal cancer: lack of prognostic model

Detalles Bibliográficos
Autor principal:	Buhmeida, Abdelbaset
Formato:	Texto
Lenguaje:	English
Publicado:	CoAction Publishing 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078229/ https://www.ncbi.nlm.nih.gov/pubmed/21503225 http://dx.doi.org/10.4176/061221

Ejemplares similares

Mutational spectrum of BRAF gene in colorectal cancer patients in Saudi Arabia
por: Rasool, Mahmood, et al.
Publicado: (2021)

Quantitative Pathology: Historical Background, Clinical Research and Application of Nuclear Morphometry and DNA Image Cytometry
por: Buhmeida, Abdelbaset
Publicado: (2006)

Comment on “Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes”
por: Loughrey, Maurice B., et al.
Publicado: (2020)

Klotho promoter methylation status and its prognostic value in ovarian cancer
por: Al-Zahrani, Maryam H., et al.
Publicado: (2021)

Cell adhesion molecules have prognostic potential in colorectal carcinoma
por: AL-Attas, Asma’a, et al.
Publicado: (2014)

Biomarkers in cancer: is ‘omices’ the way to go
por: Buhmeida, Abdelbaset, et al.
Publicado: (2011)

Lack of BRAFV600E mutation in stage I and II of colorectal cancer
por: Molaei, Mahsa, et al.
Publicado: (2016)

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
por: Okuno, Keisuke, et al.
Publicado: (2023)

Loss of Villin Immunoexpression in Colorectal Carcinoma Is Associated with Poor Differentiation and Survival
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2013)

Mismatch repair genes status in sporadic Saudi colorectal cancer patients
por: Ata, Manar, et al.
Publicado: (2014)

Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
por: Ermiah, Eramah, et al.
Publicado: (2012)

Lack of respect and balance
por: White, Margaret
Publicado: (2022)

Molecular characterization and identification of predictors of disease outcome in Saudi colorectal carcinoma
por: Buhmeida, Abdelbaset, et al.
Publicado: (2014)

Immunoexpression of cyclin D1 in colorectal carcinomas is not correlated with survival outcome
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2015)

Influence of Sampling Practices on the Appearance of DNA Image Histograms of Prostate Cells in FNAB Samples
por: Buhmeida, Abdelbaset, et al.
Publicado: (1999)

Medicine and health of 21st Century: Not just a high biotech-driven solution
por: Assidi, Mourad, et al.
Publicado: (2022)

Current Healthcare Systems in Light of Hyperendemic NCDs and the COVID-19 Pandemic: Time to Change
por: Buhmeida, Abdelbaset, et al.
Publicado: (2023)

Apoptotic activity in Libyan breast cancer
por: Boder, Jamela, et al.
Publicado: (2012)

The significance of sonic hedgehog immunohistochemical expression in colorectal carcinoma
por: Al Ghamdi, Doaa, et al.
Publicado: (2015)

c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2015)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Proliferative Activity in Libyan Breast Cancer with Comparison to European and Central African Patients
por: Boder, Jamela, et al.
Publicado: (2013)

p16 Protein is Upregulated in a Stepwise Fashion in Colorectal Adenoma and Colorectal Carcinoma
por: Al-Ahwal, Mahmoud, et al.
Publicado: (2016)

Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer
por: Al-Zahrani, Maryam H., et al.
Publicado: (2023)

Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
por: Ermiah, Eramah, et al.
Publicado: (2022)

Diagnosis delay in Libyan female breast cancer
por: Ermiah, Eramah, et al.
Publicado: (2012)

Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2017)

The prognostic influence of tumour budding in Western patients with stage II colorectal cancer
por: Canguçu, Augusto Leite, et al.
Publicado: (2020)

Author response to “lack of benefit from low dose computed tomography in screening for lung cancer”
por: Huang, Kai-Lin, et al.
Publicado: (2020)

Lack of safeguards in response to restrictive public health measures
por: Freudenthal, Robert, et al.
Publicado: (2020)

Prognostic factors in prostate cancer
por: Buhmeida, A, et al.
Publicado: (2006)

Comment on ‘Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: a meta-analysis of results from multivariate analysis’
por: Zhao, Miaoying
Publicado: (2023)

Lichen Myxedematosus: Strict Classification and Diagnostic Criteria are Still Lacking
por: Nofal, Ahmad, et al.
Publicado: (2016)

COVID Highlights Another Crisis: Lack of Black Physicians and Scientists
por: Daley, George Q., et al.
Publicado: (2021)

COVID-19 and obesity—lack of clarity, guidance, and implications for care
por: Flint, Stuart William, et al.
Publicado: (2020)

A commentary on “Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: a meta-analysis of results from multivariate analysis”
por: Qian, Yun, et al.
Publicado: (2023)

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer
por: Liu, Yue, et al.
Publicado: (2014)

GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer
por: Zhao, Zhixun, et al.
Publicado: (2018)

Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients
por: Dimitriou, Nikoletta, et al.
Publicado: (2018)

Phase III Trial of Albumin in Malaria Still Lacks Scientific Justification
por: Woodrow, Charles J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_npv9dt1s4g5v9ap9tc0pgp4ptc